Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Risk factors for development of impaired renal function in Type 2 diabetes mellitus patients in primary care.

Naushahi MJ, de Grauw WJ, Avery AJ, van Gerwen WH, van de Lisdonk EH, van Weel C.

Diabet Med. 2004 Oct;21(10):1096-101.

PMID:
15384956
2.

Estimation of glomerular filtration rate in diabetic subjects: Cockcroft formula or modification of Diet in Renal Disease study equation?

Rigalleau V, Lasseur C, Perlemoine C, Barthe N, Raffaitin C, Liu C, Chauveau P, Baillet-Blanco L, Beauvieux MC, Combe C, Gin H.

Diabetes Care. 2005 Apr;28(4):838-43.

PMID:
15793182
3.

Diabetic foot syndrome and renal function in type 1 and 2 diabetes mellitus show close association.

Wolf G, Müller N, Busch M, Eidner G, Kloos C, Hunger-Battefeld W, Müller UA.

Nephrol Dial Transplant. 2009 Jun;24(6):1896-901. doi: 10.1093/ndt/gfn724. Epub 2009 Jan 7.

PMID:
19131351
4.

Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy.

Rossing P, Rossing K, Gaede P, Pedersen O, Parving HH.

Diabetes Care. 2006 May;29(5):1024-30.

PMID:
16644632
5.

Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus.

Orth SR, Schroeder T, Ritz E, Ferrari P.

Nephrol Dial Transplant. 2005 Nov;20(11):2414-9. Epub 2005 Jul 26.

PMID:
16046507
6.

Hyperfiltration in African-American patients with type 2 diabetes. Cross-sectional and longitudinal data.

Chaiken RL, Eckert-Norton M, Bard M, Banerji MA, Palmisano J, Sachimechi I, Lebovitz HE.

Diabetes Care. 1998 Dec;21(12):2129-34.

PMID:
9839105
7.

Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment cO-existing with NIDDM [NEFRON] 11).

Thomas MC, Macisaac RJ, Jerums G, Weekes A, Moran J, Shaw JE, Atkins RC.

Diabetes Care. 2009 Aug;32(8):1497-502. doi: 10.2337/dc08-2186. Epub 2009 May 26.

8.

Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes.

Zoppini G, Targher G, Chonchol M, Perrone F, Lippi G, Muggeo M.

Nutr Metab Cardiovasc Dis. 2009 Oct;19(8):580-6. doi: 10.1016/j.numecd.2008.11.003. Epub 2009 Feb 3.

PMID:
19196499
9.

Are prediction equations for glomerular filtration rate useful for the long-term monitoring of type 2 diabetic patients?

Fontseré N, Salinas I, Bonal J, Bayés B, Riba J, Torres F, Rios J, Sanmartí A, Romero R.

Nephrol Dial Transplant. 2006 Aug;21(8):2152-8. Epub 2006 May 15.

PMID:
16702203
10.

[Risk factors for the development of diabetic nephropathy].

Antić M, Jotić A, Radović M, Seferović JP, Lalić NM, Jovanović D, Lezaić V.

Srp Arh Celok Lek. 2009 Jan-Feb;137(1-2):18-26. Serbian.

11.

An alternative formula to the Cockcroft-Gault and the modification of diet in renal diseases formulas in predicting GFR in individuals with type 1 diabetes.

Ibrahim H, Mondress M, Tello A, Fan Y, Koopmeiners J, Thomas W.

J Am Soc Nephrol. 2005 Apr;16(4):1051-60. Epub 2005 Feb 16.

12.

Management of cardiovascular risk factors in advanced type 2 diabetic nephropathy: a comparative analysis in nephrology, diabetology and primary care settings.

Minutolo R, Sasso FC, Chiodini P, Cianciaruso B, Carbonara O, Zamboli P, Tirino G, Pota A, Torella R, Conte G, De Nicola L.

J Hypertens. 2006 Aug;24(8):1655-61.

PMID:
16877970
13.

Renal hyperfiltration in type 2 diabetes: effect of age-related decline in glomerular filtration rate.

Premaratne E, Macisaac RJ, Tsalamandris C, Panagiotopoulos S, Smith T, Jerums G.

Diabetologia. 2005 Dec;48(12):2486-93. Epub 2005 Nov 1.

PMID:
16261309
14.

[Diabetic nephropathy: glomerular filtration rate and estimated creatinine clearance].

Guimarães J, Bastos M, Melo M, Carvalheiro M.

Acta Med Port. 2007 Mar-Apr;20(2):145-50. Epub 2007 Jun 11. Portuguese.

15.

[Assessment of renal function according to the NHG protocol 'Diabetes mellitus type 2': risk of overestimating the number of diabetes patients with renal dysfunction].

Bilo HJ, Logtenberg SJ, Dikkeschei LD, Kleefstra N, Wolffenbuttel BH.

Ned Tijdschr Geneeskd. 2007 May 5;151(18):1024-8. Dutch.

PMID:
17508689
16.

Effect of ACE and AT-2 inhibitors on mortality and progression to microalbuminuria in a nested case-control study of diabetic nephropathy in diabetes mellitus type 2: results from the GENDIAN study.

Böger CA, Haak T, Götz AK, Christ J, Ruff E, Hoffmann U, Riegger GA, Krämer BK.

Int J Clin Pharmacol Ther. 2006 Aug;44(8):364-74.

PMID:
16961167
17.

Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.

Ravera M, Noberasco G, Re M, Filippi A, Gallina AM, Weiss U, Cannavò R, Ravera G, Cricelli C, Deferrari G.

Nephrol Dial Transplant. 2009 May;24(5):1528-33. doi: 10.1093/ndt/gfn692. Epub 2008 Dec 10.

PMID:
19073656
18.

Association of diabetic retinopathy and renal function in patients with types 1 and 2 diabetes mellitus.

Wolf G, Müller N, Mandecka A, Müller UA.

Clin Nephrol. 2007 Aug;68(2):81-6.

PMID:
17722706
19.

Interactive effect of retinopathy and macroalbuminuria on all-cause mortality, cardiovascular and renal end points in Chinese patients with Type 2 diabetes mellitus.

Tong PC, Kong AP, So WY, Yang X, Ng MC, Ho CS, Ma RC, Ozaki R, Ng V, Chow CC, Lam CW, Chan JC, Cockram CS.

Diabet Med. 2007 Jul;24(7):741-6. Epub 2007 Apr 2.

PMID:
17403120

Supplemental Content

Support Center